← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Elex Biotech, Llc
Portland, OR
$5,713,563
Total funding
5
Grants
Funding over time
peak $1.5M · FY2012–21$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,713,563 · 5
By mechanism
R44$2,936,806 · 1
R42$1,500,383 · 1
R41$777,412 · 2
SB1$498,962 · 1
Investigators at Elex Biotech, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$999,103
R44 · FY2019 · HL
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$971,323
R44 · FY2021 · HL
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$966,380
R44 · FY2020 · HL
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$750,385
R42 · FY2015 · HL
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$749,998
R42 · FY2016 · HL
Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT$498,962
SB1 · FY2020 · HL
Development of novel compounds for the treatment of atrial fibrillation$427,638
R41 · FY2015 · HL
Rational Design of New Drugs to Treat Ventricular Arrhythmias$349,774
R41 · FY2012 · HL